MXCT compared with BLND: revenue, margins and what each company keeps, and the suppliers and customers both name

MXCTMaxcyte, Inc.

Mkt capRevenueRevenue

BLNDBlend Labs, Inc.

Mkt capRevenueRevenue

Compare

MXCTMaxcyte, Inc.

BLNDBlend Labs, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

MXCTMaxcyte, Inc.

1.45▼−1.03%

Mkt cap$150.7MRevenue$7MQ2 FY26Revenue$33MFY25

BLNDBlend Labs, Inc.

1.25▲+7.92%

Regular sessionNov 4 '26

Mkt cap$274.4MRevenue$34MQ2 FY26Revenue$124MFY25

Compare

Regular sessionNov 4 '26

MXCTMaxcyte, Inc.

BLNDBlend Labs, Inc.

1.45▼−1.03%

Price

1.25▲+7.92%

$150.7M

Mkt cap

$274.4M

Q2 FY26$7M

Revenue

$34MQ2 FY26

FY25$33M

Revenue

$124MFY25

MXCT1.45▼−1.03%vsBLND1.25▲+7.92%Regular sessionNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MXCT: latest quarter is a loss; flow not drawable. BLND: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MXCT 5

TGTXTG Therapeuticscustomer

DTILPrecision BioSciencescustomer

—SeQure Dxunlistedsupplier

—Imugene (USA)unlistedcustomer

1 more · MXCT chain ›

Shared 0

No disclosed counterparties: BLND.

Only BLND 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

MXCT, solidBLND, dashed